← Back to Search

Behavioural Intervention

Vagus Nerve Stimulation for Systemic Lupus Erythematosus

N/A
Waitlist Available
Led By Cynthia Aranow, M.D.
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 days
Awards & highlights

Summary

This trial is testing a new treatment for people with Systemic Lupus Erythematosus (SLE) who have musculoskeletal pain. The treatment involves using a device to send mild electrical signals to the vagus nerve through the skin. This process aims to reduce pain and inflammation by activating the body's natural anti-inflammatory pathway. Recent studies suggest that this method has few side effects and beneficial effects on fatigue, pain, disease activity, and organ function.

Eligible Conditions
  • Systemic Lupus Erythematosus
  • Musculoskeletal Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Musculoskeletal pain.
Secondary study objectives
Fatigue
Musculoskeletal Pain
Therapeutic procedure
+3 more
Other study objectives
CpG stimulated levels of TNF, IL-6, Il1B, IFNα and IL10 in whole blood.
Interleukin-1
HMGB1 Protein
+2 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Vagus Nerve StimulationActive Control1 Intervention
Subjects randomized to this arm will receive transcutaneous vagus nerve stimulation for 5 minutes on 4 consecutive days.
Group II: Sham Vagus Nerve StimulationPlacebo Group1 Intervention
Subjects randomized to this arm will receive sham stimulation for 5 minutes for 4 consecutive days.

Find a Location

Who is running the clinical trial?

Northwell HealthLead Sponsor
473 Previous Clinical Trials
472,254 Total Patients Enrolled
John and Marcia Goldman FoundationUNKNOWN
Cynthia Aranow, M.D.Principal InvestigatorNorthwell Health
1 Previous Clinical Trials
43 Total Patients Enrolled
~2 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top